Properties (58)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:administrativeDivision |
once daily
|
| gptkbp:analyzes |
clinical researchers
IND_application_submitted |
| gptkbp:chemicalFormula |
small molecule
|
| gptkbp:clinicalTrials |
gptkb:Canada
gptkb:United_States Europe Phase 2b randomized controlled trial MyoKardia not yet available |
| gptkbp:collaborations |
various research institutions
|
| gptkbp:collection |
clinical assessments
|
| gptkbp:community_service |
not established
heart function improvement |
| gptkbp:contraindication |
under study
|
| gptkbp:court |
pending
|
| gptkbp:developedBy |
MyoKardia
|
| gptkbp:dosageForm |
tablet
|
| gptkbp:drugInterdiction |
cardiac myosin inhibitors
|
| gptkbp:evaluates |
to be collected
|
| gptkbp:firstAppearance |
not yet approved
|
| gptkbp:formulation |
film-coated tablet
|
| gptkbp:future_plans |
Phase 2
|
| gptkbp:hasPopulation |
hypertrophic_cardiomyopathy_patients
|
| gptkbp:healthcare |
active
specific criteria |
| https://www.w3.org/2000/01/rdf-schema#label |
MYO-101
|
| gptkbp:impact |
varies by trial
|
| gptkbp:mandates |
gptkb:cardiomyopathy
|
| gptkbp:market |
not available
|
| gptkbp:patentStatus |
patented
|
| gptkbp:productionCompany |
investigational
|
| gptkbp:regulatoryCompliance |
under review
|
| gptkbp:research |
public and private sources
ongoing studies pharmacological study |
| gptkbp:research_areas |
cardiology
|
| gptkbp:researchAndDevelopment |
efficacy and safety
|
| gptkbp:researchAreas |
ongoing
|
| gptkbp:researchFocus |
cardiac diseases
|
| gptkbp:researchInterest |
academic institutions
pending to be published improve cardiac function |
| gptkbp:route |
oral
|
| gptkbp:safetyFeatures |
ongoing
under investigation to be collected |
| gptkbp:sideEffect |
dizziness
fatigue headache nausea |
| gptkbp:status |
clinical trial
|
| gptkbp:targets |
adults
hypertrophic cardiomyopathy |
| gptkbp:triggerType |
myosin inhibitor
|